Frustration Drives Japan To Allow Generics Before Side Patents Expire
This article was originally published in PharmAsia News
Executive Summary
TOKYO - In a continuing effort to raise generic drug use, Japan's Ministry of Health, Labor and Welfare has decided to allow generic drugs to be manufactured even before brand drugs' side patents expire, the ministry's Insurance Bureau officials said